Immune cell-derived C3a and C5a costimulate human T cell alloimmunity

Keyphrases

• Immune Cells 100%
• T Cells 100%
• Cell-derived 100%
• Alloimmunization 100%
• C3aR 57%
• C5aR 57%
• Dendritic Cells 42%
• T Cell Proliferation 28%
• Costimulatory Molecules 28%
• Graft-versus-host Disease (GvHD) 28%
• Akt Phosphorylation 14%
• T Cell Immunity 14%
• SiRNA Knockdown 14%
• CD4+ T 14%
• Recombinant 14%
• Antigen-presenting Cells 14%
• T Cell Response 14%
• Inhibitory Effect 14%
• T-cell Mediated 14%
• Cellular Expression 14%
• In Vitro Culture 14%
• Alloreactive 14%
• Prolonged Survival 14%
• Decay Accelerating Factor 14%
• C5a Receptor 14%
• CD4 T Cells 14%
• Tolerogenic Dendritic Cells 14%
• Disease Score 14%
• Cytotoxic T-lymphocyte antigen-4 (CTLA-4) 14%
• Reduced Graft 14%
• Peripheral Blood Mononuclear Cells 14%
• Complement Regulatory Proteins 14%
• Protein Decay 14%
• Cell Expansion 14%
• Complement Activation Products 14%
• Receptor Blockade 14%
• Cell Signaling Pathways 14%
• Alloresponse 14%
• T Cell Signaling 14%
• Organ Transplant Rejection 14%
• Scid 14%
• C5aR Antagonist 14%
• Xenogeneic Graft-versus-host Disease 14%

Immunology and Microbiology

• Immunocompetent Cell 100%
• T Cell 100%
• Complement Component 5a 100%
• Alloimmunity 100%
• Dendritic Cell 57%
• Graft-Versus-Host Disease 42%
• T-Helper Cell 28%
• T Cell Proliferation 28%
• Adoptive Immunity 14%
• Antigen Presenting Cell 14%
• Antigen-Presenting Cell 14%
• Complement Component C5a Receptor 14%
• Transplant Rejection 14%
• Decay-Accelerating Factor 14%
• Cell Expansion 14%
• Complement Activation 14%
• Receptor Blocking 14%
• T-Cell Signaling 14%
• Abatacept 14%
• Peripheral Blood Mononuclear Cell 14%
• In Vitro 14%